C1 Inhibitor (Human) (Haegarda) and Mogamulizumab-kpkc
Determining the interaction of C1 Inhibitor (Human) (Haegarda) and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 Inhibitor (Human) (Haegarda)-Mogamulizumab-kpkc Intravenous
- C1 Inhibitor (Human) (Haegarda)-Molindone
- C1 Inhibitor (Human) (Haegarda)-Mometasone (Oral Inhalation)
- C1 Inhibitor (Human) (Haegarda)-Mometasone and Formoterol
- C1 Inhibitor (Human) (Haegarda)-Mometasone and formoterol Inhalation
- C1 Inhibitor (Human) (Haegarda)-Mometasone Cream
- Mogamulizumab-kpkc-C1 Inhibitor (Recombinant)
- Mogamulizumab-kpkc-C1-Esterase Inhibitor (Human)
- Mogamulizumab-kpkc-C1-Esterase Inhibitor (Recombinant)
- Mogamulizumab-kpkc-Cabazitaxel
- Mogamulizumab-kpkc-Cabazitaxel Intravenous
- Mogamulizumab-kpkc-Cabergoline